SCHEMBL4778369

SCHEMBL4778369

Fc1ccccc1N1CC2C(C1)C2N(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.40
KDM4E B2RXH2 6/20 0.40
ALDH1A1 P00352 4/20 0.40
KMT2A Q03164 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
LMNA P02545 1/20 0.38
DRD2 P14416 2/20 0.37
DRD3 P35462 2/20 0.37
DRD4 P21917 1/20 0.37
POLB P06746 1/20 0.37
TSHR P16473 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
HSD17B10 Q99714 2/20 0.36
CHRM4 P08173 2/20 0.36
MEN1 O00255 1/20 0.36
TP53 P04637 1/20 0.36
GAA P10253 1/20 0.36
ALOX15 P16050 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4780332 0.90 CHRM4 (0.38) NOTUMKDM4EALDH1A1KMT2ATDP1
SCHEMBL4321609 0.86 GRM5 (0.42) ALDH1A1KMT2ADRD2DRD3CHRM4
SCHEMBL4780326 0.86 CHRM4 (0.40) KDM4EALDH1A1DRD2DRD3SMN1; SMN2
SCHEMBL4774390 0.85 KDM4E (0.40) KDM4EALDH1A1KMT2ATDP1DRD2
SCHEMBL4774338 0.85 DRD2 (0.32) KDM4EALDH1A1TDP1DRD2DRD3
SCHEMBL4779536 0.85 DRD2 (0.32) KDM4EALDH1A1TDP1DRD2DRD3
SCHEMBL4779787 0.84 FFAR4 (0.38) KMT2ALMNAPOLBMEN1
SCHEMBL4781178 0.84 UBE2M (0.39) ALDH1A1KMT2ALMNAPOLBSMN1; SMN2
SCHEMBL4776176 0.82 FFAR4 (0.40) KMT2AMEN1
SCHEMBL4781028 0.82 KDM4E (0.43) NOTUMKDM4EALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008010061-A2 3-AZABICYCLO [3.1.0] HEXANE VANILLOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESSES FOR THEIR PREPARATION GLENMARK PHARMACEUTICALS S.A. (US) 2008-01-24 WO disclosed